Nursing care
Triptans: what to check before you give it
Written and reviewed by Dana Whitfield, RN, MSN · 4 min read · Updated September 2026
Short answer
Triptans are serotonin receptor agonists used to abort an acute migraine attack, most effective when taken at the first sign of headache or aura. They are contraindicated in coronary artery disease and other vascular conditions because they cause vasoconstriction, and dosing is limited to no more than two doses in 24 hours.
Mechanism, simply
Triptans act as agonists at serotonin 5-HT1B and 5-HT1D receptors, causing vasoconstriction of dilated cranial blood vessels and inhibiting the release of inflammatory neuropeptides around the trigeminal nerve. Migraine pain is driven in part by vasodilation and neurogenic inflammation, so reversing the vessel dilation and quieting the inflammatory cascade interrupts the attack rather than simply masking the pain.
This mechanism is also the source of the drug class's main safety concern. The same vasoconstriction that relieves a migraine in the cranial circulation can constrict coronary and peripheral vessels, which is why cardiac history matters more with triptans than with most other headache medications.
Indications you will see on the ward
Triptans are used for acute migraine with or without aura, and some formulations are used for cluster headache. They are abortive agents, meant to stop an attack already underway, not preventive agents taken daily to reduce attack frequency; confusing the two is a common student error.
Timing drives effectiveness. Triptans work best when taken at the first sign of migraine onset, before the headache becomes severe or before cutaneous allodynia sets in. A patient who waits until the pain peaks often gets a weaker response, which is why teaching patients to keep the medication accessible and to act early is part of the nursing plan.
Assessment before administration
Before giving a triptan, assess cardiovascular history: coronary artery disease, uncontrolled hypertension, prior myocardial infarction, stroke, or peripheral vascular disease. These are contraindications, not relative cautions, because the vasoconstrictive effect can precipitate ischemia in vessels that are already compromised.
Confirm the diagnosis is migraine and not another headache type, since triptans are not appropriate for tension or other vascular headaches with a different mechanism. Ask about medications the patient is already taking, particularly other serotonergic drugs, and confirm how many doses have been taken in the current 24-hour period before administering another.
Toxicity and the antidote
There is no specific antidote for triptan toxicity. Overdose or excessive dosing manifests as exaggerated vasoconstrictive effects: chest tightness, hypertension, and in severe cases, coronary vasospasm or myocardial ischemia, alongside the paresthesia and flushing seen even at therapeutic doses.
The practical safety limit nurses must enforce is dosing frequency: no more than two doses of a triptan in 24 hours, with a minimum interval between doses as specified for that agent. Exceeding this increases cumulative vasoconstrictive burden without added benefit, and a patient requesting more than the maximum should prompt reassessment of the migraine plan rather than simply supplying another dose.
Interactions that matter
The interaction with the highest stakes is serotonin syndrome. Combining a triptan with an SSRI, SNRI, MAOI, or another serotonergic drug increases the risk of agitation, hyperthermia, tremor, and autonomic instability, and this combination should prompt closer monitoring or a discussion with the prescriber about alternatives.
Ergot derivatives, such as ergotamine, must not be given within 24 hours of a triptan, since both drug classes cause vasoconstriction and the combined effect raises the risk of prolonged vasospasm. MAOIs also reduce triptan metabolism, raising blood levels and toxicity risk, so the two are generally avoided together.
What the patient must be told
Teach patients to take the triptan at the very first sign of migraine, not after waiting to see if the headache will resolve on its own, since early treatment produces the best response. Teach the two-dose ceiling in 24 hours explicitly, and instruct patients to contact their prescriber rather than repeatedly exceeding it if migraines are not controlled.
Warn patients about tingling, flushing, and chest or throat tightness, which are common and usually benign triptan sensations, but instruct them to seek immediate care for true chest pain, since this could indicate coronary vasospasm rather than the expected sensation. Reinforce that anyone with known heart disease should not use triptans and should discuss alternative migraine treatment with their prescriber.
The next step on this is the same as on everything else here: answer questions and read the rationales. Our neurological practice questions are the closest set to what this page covers.
Common questions
When should a triptan be taken for migraine?
As early as possible, ideally at the very first sign of migraine onset or aura. Waiting until the headache is already severe reduces how effective the medication will be.
Why are triptans contraindicated in heart disease?
Triptans work by constricting dilated cranial blood vessels, but this vasoconstrictive effect is not limited to the head. In a patient with coronary artery disease or other vascular disease, it can precipitate ischemia or vasospasm in already compromised vessels.
How many triptan doses are allowed in 24 hours?
No more than two doses in a 24-hour period, with a minimum interval between doses specified for the particular agent. A patient needing more than this should be reassessed rather than simply given another dose.
Can triptans be combined with antidepressants?
Combining a triptan with an SSRI, SNRI, or MAOI raises the risk of serotonin syndrome, presenting as agitation, hyperthermia, and autonomic instability. This combination needs closer monitoring and should be discussed with the prescriber before use.
Are triptans used to prevent migraines?
No. Triptans are abortive agents taken to stop a migraine attack already in progress, not preventive medications taken daily. Migraine prevention uses a different drug class entirely.